You are here

Subscribe

Prostate & Urologic Cancer Center Blog

All
All

DCI Center for Prostate & Urologic Cancers Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Jessica Hyland, Editor-In-Chief.

Duke Scientists Receive NCI R01 Grant

The National Cancer Institute (NCI) awarded $2.1 Million to Duke Cancer Institute (DCI) researchers to study plasmonic nanoparticle-mediated immunotherapy to treat metastatic bladder cancer. Co-principal investigators, Brant Inman, MD, MS, and Tuan Vo-Dinh, PhD, developed a novel two-pronged...

Team Easy Riders: Committed To Changing The Course Of Cancer

According to the American Cancer Society, one in two men and one in three women in the United States will be affected by cancer in their lifetime. It is estimated that in 2018 there will be 1,762,450 new cancer cases diagnosed — 58,690 of those in North Carolina. In keeping with its mission to...

DCI Center for Prostate & Urologic Cancers Present at EAU

Physician-scientists from DCI Center for Prostate & Urologic Cancers recently presented data at the 2019 European Association of Urology (EAU) Congress held in Barcelona, Spain, from March 15 -19. Held annually, over 10,000 colleagues throughout the world gather for the scientific retreat to...

Blood Tests Predict Effectiveness of Hormonal Therapies

A multi-institutional group of clinical researchers, led by the Duke Cancer Institute’s Andrew Armstrong, MD, McS, FACP, published a new report this month in the Journal of Clinical Oncology , that describes results from the PROPHECY study, which prospectively compared two blood tests to assess how...

Duke Abstracts Accepted For Presentation At 2019 GU ASCO Symposium

The DCI Center for Prostate & Urologic Cancers has 18 abstracts accepted for presentation at the 2019 Genitourinary Cancers (GU) Symposium of the American Society of Clinical Oncology (ASCO) taking place Thursday, Feb. 14 through Saturday, Feb. 16 in San Francisco, California. Held annually,...

Study Signals Survival Benefit for Black Men on New Prostate Cancer Drugs

It used to be a statistical fact that African-American men fared worse than whites when battling prostate cancer. But recent research led by scientists at the Duke Cancer Institute has been challenging that notion. Added evidence will be presented Feb. 11 at a meeting of the American Society of...

Shave The Date

Things have been quite hairy around Duke University the month of November. Join the MoDukes as they wrap up #Movember on Friday, Nov. 30 at 7 p.m. for the third annual “Bid Your Face Off” event at Fullsteam brewery. The event, which is a “Bid Your Face Off” auction gala, will feature creative...

DCI Launches Center for Prostate & Urologic Cancers

Duke Cancer Institute (DCI) officially launched the new DCI Center for Prostate & Urologic Cancers, a center of excellence supporting a growing multi-disciplinary clinical and translational research team. The DCI Center for Prostate & Urologic Cancers will be led by a multi-disciplinary...

New Prostate Cancer Prognostic Model For Enzalutamide

Researchers at the Duke Prostate & Urologic Cancer Center, led by genitourinary oncologist Andrew Armstrong, MD, have recently developed a novel nomogram, a prognostic model that measures overall survival for men with metastatic prostate cancer who were treated with enzalutamide, according to...

#RunYourStory: Surviving The Marathon

Physician burnout is at its highest level in history. According to a recent study in the American Journal of Medicine, physician-reported burnout increased significantly from 45.5 percent in 2011 to 54.4 percent in 2014. These numbers are also significantly higher than that of the general workforce...

Over 150 Men Screened For Prostate Cancer

This year, over 150 men participated in the annual Men's Health Initiative. For the past two decades, the Office of Health Equity at Duke Cancer Institute in partnership with Lincoln Community Health Center has co-hosted MHI, an outreach event aimed at screening men, particularly African American...

McNamara Receives PCF Young Investigator Award

Megan McNamara, MD, has been named one of 29 Prostate Cancer Foundation Young Investigator Award recipients for 2018. McNamara is also one of only eleven PCF Young Investigator Awardees conducting research to improve prostate cancer outcomes in U.S. veterans. The award includes three years of...

Pages